Zobrazeno 1 - 10
of 496
pro vyhledávání: '"Anders, Jakobsen"'
Autor:
Sinne Søberg Brun, Torben Frøstrup Hansen, Sara Witting Christensen Wen, Christa Haugaard Nyhus, Lisbeth Bertelsen, Anders Jakobsen, Torben Schjødt Hansen, Line Nederby
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Many studies have focused on the prognostic role of soluble programmed death ligand 1 (sPD-L1) in non-small cell lung cancer (NSCLC), but outcomes are ambiguous and further investigations are needed. We addressed the matter by studying sPD-L
Externí odkaz:
https://doaj.org/article/de6468f3c6e3447088497815bde82608
Autor:
Ina Mathilde Kjær, Søren Kahns, Signe Timm, Rikke Fredslund Andersen, Jonna Skov Madsen, Erik Hugger Jakobsen, Tomasz Piotr Tabor, Anders Jakobsen, Troels Bechmann
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Neoadjuvant treatment of breast cancer is applied to an increasing extent, but treatment response varies and side effects pose a challenge. The vitamin E isoform delta-tocotrienol might enhance the efficacy of chemotherapy and reduce the ris
Externí odkaz:
https://doaj.org/article/f4ad326d50c84c1381d62529a838f34c
Autor:
Ishith Seth, BBiomed(Hons), MD, MSurg, Joakim Lindhardt, B. Eng., Anders Jakobsen, B. Eng., Jørn Bo Thomsen, MD, PhD, Birgitte Jul Kiil, MD, Warren Matthew Rozen, MBBS, BMedSc, MD, PhD, FRACS, Peter Sinkjaer Kenney, MD, PhD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 11, Iss 9, p e5282 (2023)
Background:. Augmented reality (AR) technology, exemplified by devices such as the Microsoft HoloLens 2, has gained interest for its potential applications in preoperative guidance. This study explores the use of AR technology for perforator identifi
Externí odkaz:
https://doaj.org/article/0932d6f3fa24475dab33ffb442d44e31
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Interest in the measurement of circulating tumor DNA (ctDNA) in colorectal cancer (CRC) has increased during the past decade. The analysis of quantitative ctDNA changes as a general response evaluation criterion during systemic treatment is a scienti
Externí odkaz:
https://doaj.org/article/1d7e9a290c5a4061a2ec34857556dae7
Autor:
Mette Haldup, Engr Anders Jakobsen, Mads Rasmussen, Stig Dyrskog, Claus Simonsen, Mads Grønhæj, Dr Frantz Poulsen, Dr Anders Korshøj
Publikováno v:
Brain and Spine, Vol 3, Iss , Pp 102025- (2023)
Externí odkaz:
https://doaj.org/article/595af8501f6f44a2b2bee00a1dbd15ed
Autor:
Morten Borg, Sara Witting Christensen Wen, Torben Frøstrup Hansen, Anders Jakobsen, Rikke Fredslund Andersen, Ole Hilberg, Ulla Møller Weinreich, Line Nederby
Publikováno v:
Journal of International Medical Research, Vol 50 (2022)
Objective Natural killer (NK) cells play an essential role in the immune response against cancer. However, immune escape mechanisms may cause inferior NK cell activity (NKA) in patients with cancer. This prospective study examined the relationship be
Externí odkaz:
https://doaj.org/article/98d79f5b73f64adfaed8e24a84beff98
Autor:
Caroline Brenner Thomsen, Rikke Fredslund Andersen, Lars Henrik Jensen, Anders Jakobsen, Torben Frøstrup Hansen
Publikováno v:
Gastrointestinal Disorders, Vol 2, Iss 4, Pp 378-384 (2020)
Background: Organ preservation in the treatment of rectal cancer has seen an increase in interest. Clinical complete response (cCR) after high-dose chemoradiotherapy (CRT) allows for non-surgical management (NSM), but the selection of patients is cha
Externí odkaz:
https://doaj.org/article/928211df13f947e485382f065c666d0d
Autor:
Jon Røikjær Henriksen, Line Nederby, Frede Donskov, Marianne Waldstrøm, Parvin Adimi, Anders Jakobsen, Karina Dahl Steffensen
Publikováno v:
Journal of Ovarian Research, Vol 13, Iss 1, Pp 1-9 (2020)
Abstract Purpose Biomarkers are needed to guide treatment decisions in recurrent ovarian cancer, as a high proportion of patients do not benefit from treatments. Data on immune subsets in patients receiving chemotherapy are scarce. We investigated th
Externí odkaz:
https://doaj.org/article/fb7aa638f37d4fd7b7004e3d055162c6
Autor:
Torben Frøstrup Hansen, Line Nederby, Ahmed H. Zedan, Inge Mejlholm, Jon R. Henriksen, Karina D. Steffensen, Caroline B. Thomsen, Louise Raunkilde, Lars Henrik Jensen, Anders Jakobsen
Publikováno v:
Translational Oncology, Vol 12, Iss 7, Pp 968-972 (2019)
INTRODUCTION: The aim of the present study was to analyze the possible correlation between Natural Killer (NK) cell activity as measured by the NK Vue assay and treatment efficacy in patients with disseminated cancer. MATERIALS AND METHODS: The study
Externí odkaz:
https://doaj.org/article/addddd0d570e43a1a92a4b84f831cd0d
Autor:
Caroline B. Thomsen, Torben F. Hansen, Rikke F. Andersen, Jan Lindebjerg, Lars H. Jensen, Anders Jakobsen
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: The early identification of treatment effect is wanted in several settings, including the management of metastatic colorectal cancer (mCRC). A potential universal marker is circulating tumor DNA (ctDNA). Our prospective study explored the
Externí odkaz:
https://doaj.org/article/7691c5fcc85d4275bf673f1042e721cd